News

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...
NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.
The US FDA has approved Moderna's new COVID-19 vaccine, mNEXSPIKE, amidst emerging coronavirus variants. It is approved for ...
Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...
Infectious disease experts say mRNA vaccines have been studied for decades, they are safe and effective, and were ...
This week, mRNA vaccines are set to face intense scrutiny from critics in Congress. Here's an explainer of how we know they ...
CAMBRIDGE, MASS. — The US Department of Health and Human Services (HHS) notified pharmaceutical company Moderna Inc. on May ...
Robert F. Kennedy Jr. continues his anti-vax crusade by cancelling million-dollar bird flu vaccine deal with Moderna.
In another sign of growing scrutiny over Covid-19 vaccines, the Food and Drug Administration has asked the two makers of mRNA ...
The U.S. government is pulling its funding for drugmaker Moderna to continue testing an mRNA vaccine intended to protect people from the bird flu.
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...
The Trump administration said it was cancelling $766 million in funding for a Moderna vaccine contract that was supposed to help pay for the development of a shot that would protect people against ...